Investment for health and wellbeing

Join our Q2 2024 results webcast on 18 July 2024 at 10 a.m. EEST >>

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Half-Year Report 2024

Oriola will publish its Half-Year Report for January-June 2024 on Thursday 18 July 2024 at around 8.30 a.m. Welcome to join our results presentation as a live webcast at 10 a.m. on the same day.

Join the webcast See the invitation

Interim Report Q1 2024

Sales growth and improved profitability

Download Q1 report Download Q1 presentation Watch the webcast CEO blog

Annual Report 2023

Our Annual Report consists of the following sections: Business review, Sustainability report, Corporate governance statement, Remuneration report, Report of the Board of Directors and Financial statements.

Find out more

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

06.06.2024 | Stock exchange releases

Composition of Oriola Corporation’s Shareholders’ Nomination Board
30.04.2024 | Stock exchange releases

The Swedish Competition Authority prohibits Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB
25.04.2024 | Stock exchange releases

Oriola Corporation’s Interim Report January-March 2024
See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts